[Notice] Celltrion website renewed
- Improved convenience and accessibility of users by implementation of responsive web
- Various multimedia content related to biosimilars
Celltrion is strengthening its communication with the public through renewal of the company website and launching it on June 1st.
The newly reformed website is customized for users to find required information conveniently, and application of responsive web automatically optimizes according to the device being used such as laptop, tablet PC and smartphones and improved UI/UX for the convenience of impaired users.
The new website lowers the threshold so that the general public can access the industry easier by providing fundamental knowledge through videos and infographics to assist in the understanding of biosimilars.
Furthermore, the website now introduces the development and authorization process of the world’s first developed antibody biosimilar ‘Remsima’ through the promotional video of a panorama of Celltrion and its researching staff.
In addition, real-time updates on recruitment, philosophy, IR information and press release can also be found.